JB Pharma reports revenue growth of 9 per cent to Rs 882 crores in Q2 FY24
PAT increased by 36 per cent to Rs 151 crores
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
USV, Biogenomics launch INSUQUICK, biosimilar Insulin Aspart for diabetes treatment
Insuquick will be available in cartridges, vials, and prefilled disposable pens
Myasthenia gravis market to generate sales of $6.7 bn across 7MM by 2032: GlobalData
GlobalData identified the influx of several new disease-modifying therapies (DMTs) within the past two years as the main driver of…
Biocon Biologics signs pact with Eris Lifesciences for divesture of dermatology and nephrology…
Total transaction value of the divestment is Rs 3,660 million, inclusive of working capital conveyed as part of the deal
Lupin launches Rocuronium Bromide Injection in US
It is indicated as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to…
Accent Microcell files DRHP with NSE Emerge
The company will use net proceeds from the issue to invest in setting up a new plant at Navagam Kheda in Gujarat; it operates two…
GLP1R-targeting drugs dominate type 2 diabetes pipeline: GlobalData
This indicates a shift from the conventional IR to the GLP1R as the primary target for pioneering T2D treatments
Glenmark gets USFDA nod for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, 10 mg
The tablets will be distributed in the US by Glenmark Pharmaceuticals US
Zydus gets USFDA nod for ZITUVIMET to treat adults with type 2 diabetes
ZITUVIMET contains active ingredients sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride, a…
Venus Remedies gets Three Star Export House Certificate from Govt of India
Previously, Venus Remedies held the Two Star Export House status, which required meeting export performance criteria of $25…
Penbraya approval sparks shift to pentavalent meningococcal vaccines in US: GlobalData
GSK is also in the process of developing a pentavalent vaccine, and positive Phase III data were announced earlier this year.…
Lupin, Zydus sign licensing pact to co-market Saroglitazar Mg for chronic liver diseases in India
In 2020, Saroglitazar Mg received approval for the treatment of NASH and NAFLD
Novel therapies to drive Crohn’s disease market growth across 8MM to $15 bn by 2032: GlobalData
An anticipated 11 assets in the late-stage pipeline will enter the CD market during the forecast period
ImmunoACT to lead journey of indigenous CAR-T cell therapy in India but market access a hurdle:…
As per ImmunoACT CEO, NexCAR19 will be available at a price of Rs 30-40 lakh ($36,000- $48,000), which is 1/10th of the cost of…
Zydus acquires LiqMeds Group
Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026 depending on achievement of certain…
Aragen setting up a $ 30mn bio-manufacturing site in Bengaluru
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
FDA rejection to delay Lebrikizumab chances to enter atopic dermatitis market: GlobalData
GlobalData currently expects Lilly to resubmit lebrikizumab’s BLA in Q4 2023
Pharma, healthcare sector attract investment despite volume dip in Q3 2023: Report
The quarter saw 26 deals totalling $2.7 billion, with a 32 per cent decline in deal volumes compared to Q3 2022
Top 20 global biopharma cos report marginal growth in market cap during Q3 2023: GlobalData
Out of the top 20 companies, nine saw their market capitalisation surge by more than 10 per cent, with significant gains achieved…
Sun Pharma, Zydus sign licensing pact to co-market Desidustat for CKD treatment in India
The drug will be marketed by Sun Pharma under the brand name RYTSTAT. Zydus continues to market the drug under the brand name…